Skip to content
RxMonitor home

Medication

Blexten

DIN 02454130 · Aralez Pharmaceuticals Canada Inc

What it is

Active ingredients
  • Bilastine — 20 mg
Form and route
Tablet · Oral
Schedule
PRESCRIPTION
Status
Marketed

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.

Products with the same active ingredient

Grouped by Health Canada’s active-ingredient group number. Sharing an active ingredient is not the same as being interchangeable — that is a provincial determination, and it is not shown on this page.

Recalls and safety alerts

Recall matching is not available yet.

RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.

Search Health Canada recalls for Blexten →

Important:

Information only — this is not medical advice. RxMonitor shows what Health Canada and provincial drug programs have published about authorised products. It does not tell you what to take, whether a medication is right for you, or what dose to use.

Always talk to a pharmacist or physician about your own medication, and never start, stop or change one based on what you read here.